These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1071404

  • 21. Diuretic therapy and response of essential hypertension to saralasin.
    Anderson GH, Dalakos TG, Elias A, Tomycz N, Streeten DH.
    Ann Intern Med; 1977 Aug; 87(2):183-7. PubMed ID: 889199
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H, Leth A, McNair A, Giese J.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [Abstract] [Full Text] [Related]

  • 24. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Lancet; 1975 Oct 25; 2(7939):784-7. PubMed ID: 78152
    [Abstract] [Full Text] [Related]

  • 25. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP, Ledingham JG.
    Clin Sci Mol Med; 1978 Mar 25; 54(3):305-12. PubMed ID: 630806
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.
    Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA.
    J Hypertens; 1985 Jun 25; 3(3):243-7. PubMed ID: 3894515
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Angiotensin II and not sodium status is the major determinant of the agonistic/antagonistic balance of saralasin's actions.
    Fagard R, Amery A, Lijnen P.
    Clin Sci (Lond); 1980 Dec 25; 59 Suppl 6():75s-78s. PubMed ID: 7004740
    [Abstract] [Full Text] [Related]

  • 33. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ, Boyd GW, Peart WS.
    Circ Res; 1975 Nov 25; 37(5):640-6. PubMed ID: 1192561
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.
    Klin Wochenschr; 1978 Nov 25; 56 Suppl 1():97-105. PubMed ID: 732257
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin blockade: its clinical significance.
    Streeten DH, Anderson GH, Dalakos TH.
    Am J Med; 1976 May 31; 60(6):817-24. PubMed ID: 1020761
    [Abstract] [Full Text] [Related]

  • 36. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E, Brown JJ, Brown WC, Fraser R, Trust PM, Lever AF, Morton JJ, Robertson JI.
    Clin Endocrinol (Oxf); 1979 Mar 31; 10(3):227-34. PubMed ID: 455738
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar 31; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.